Creative Touch Permanent Makeup and Aesthetics

Leptin is a peptide hormone produced by adipose tissue in direct proportion to fat mass, functioning as the body’s long-term energy store reporter to the hypothalamus. When fat stores are adequate, circulating leptin signals the brain to suppress appetite, increase energy expenditure, and reduce food-seeking behaviour. The paradox of leptin – and the clinical reality for most people managing weight – is that obesity produces chronically elevated leptin levels rather than the expected satiety, because sustained hyperleptinemia drives downregulation of hypothalamic leptin receptor signalling. This leptin resistance means the satiety signal is present but no longer heard. Beyond appetite regulation, leptin plays established roles in immune function, wound healing, and keratinocyte proliferation, making it a hormone whose consequences extend well beyond the scales and into the skin’s capacity for repair and renewal. ^[2]

Leptin was identified in 1994 through positional cloning of the mouse obese (ob) gene – the same gene whose mutation produces the severely obese ob/ob mouse phenotype. The discovery generated enormous clinical excitement: a hormone produced by fat tissue that suppressed appetite suggested an obvious therapeutic route to treating obesity. That excitement was substantially tempered within a few years when it became clear that most obese individuals already had elevated leptin levels, and that their bodies had largely stopped responding to it. The story of leptin is therefore less about a simple on/off satiety switch and more about a system that works well at normal weight and progressively fails as adiposity increases.

What Leptin Is and Where It Comes From

Leptin is a 16 kDa peptide hormone encoded by the LEP gene and produced primarily by white adipose tissue, with smaller contributions from brown adipose tissue, the placenta, stomach, and skeletal muscle. Its circulating concentration is directly proportional to total fat mass: lean individuals have low leptin, obese individuals have high leptin, and changes in fat mass – in either direction – are reflected in circulating leptin within hours to days. Women consistently have higher leptin levels than men at equivalent body fat percentages, due to the influence of oestrogen on LEP gene expression and differences in adipose tissue distribution. ^[1]

Leptin crosses the blood-brain barrier via a saturable transport system involving the short form of the leptin receptor (LepRa) on choroid plexus and cerebrovascular endothelial cells. The transport system’s saturability is clinically important: at high circulating leptin concentrations, transport becomes rate-limiting, reducing the proportion of leptin that reaches hypothalamic receptor populations even as blood levels continue to rise. This transport impairment is one of the mechanisms through which hyperleptinemia paradoxically produces central leptin resistance. ^[3]

How Leptin Works: The Satiety Signal

Leptin’s primary signalling target is the arcuate nucleus of the hypothalamus, where it acts on two opposing neuronal populations. It activates pro-opiomelanocortin (POMC) neurons, which produce α-melanocyte-stimulating hormone (α-MSH) – a satiety signal that activates melanocortin-4 receptors (MC4R) on downstream neurons to suppress appetite and increase energy expenditure. Simultaneously, leptin inhibits NPY/ AgRP neurons, which promote feeding and suppress energy use. The net effect is reduced appetite and increased metabolic rate – the expected response to adequate fat stores. ^[2]

Leptin receptor signalling operates primarily through the JAK2-STAT3 pathway: leptin binding to the long form of its receptor (LepRb) activates Janus kinase 2 (JAK2), which phosphorylates STAT3. Phosphorylated STAT3 translocates to the nucleus and drives expression of appetite-suppressing genes whilst upregulating SOCS3 – suppressor of cytokine signalling 3 – which acts as a negative feedback brake on leptin receptor activity. Under normal conditions this feedback is appropriate and prevents overstimulation. In leptin resistance, SOCS3 upregulation becomes constitutive and excessive, persistently dampening the receptor signal even when leptin concentrations are high. ^[3]

Leptin Resistance: The Central Clinical Problem

Leptin resistance is the state in which chronically elevated leptin fails to produce proportionate appetite suppression or energy expenditure increases. It is the defining feature of the leptin system in obesity and the reason that the initial therapeutic promise of leptin largely failed to translate – injecting more leptin into an already leptin-resistant system produces diminishing returns.

The mechanisms of leptin resistance are multiple and compounding. ^[3]

Impaired blood-brain barrier transport. The saturable LepRa transport system becomes rate-limiting at high leptin concentrations, reducing central leptin availability despite elevated blood levels.

SOCS3-mediated receptor desensitisation. Chronic leptin receptor activation upregulates SOCS3, which phosphorylates and inactivates JAK2, progressively blunting the downstream STAT3 signal. This self-reinforcing mechanism means that the higher leptin rises, the less effectively it signals – a vicious cycle that entrenches with duration of obesity.

Hypothalamic inflammation. This is perhaps the most clinically significant mechanism for this knowledge base. High-fat dietary patterns drive hypothalamic inflammation through microglial activation and pro-inflammatory cytokine release – TNF-α, IL-6, and IL-1β all impair leptin receptor signalling in arcuate neurons, independently of SOCS3. The same chronic inflammation that drives systemic metabolic dysfunction progressively silences the brain’s own satiety detector. This is why dietary patterns matter not just calorically but architecturally: chronic consumption of ultra-processed, high-fat, high-sugar foods can degrade leptin sensitivity through hypothalamic inflammation in ways that persist beyond the dietary pattern itself. ^[3]

ER stress. Obesity-associated endoplasmic reticulum stress in hypothalamic neurons activates the unfolded protein response, which also impairs JAK2-STAT3 signalling downstream of leptin receptor activation.

Clinical Pearl Leptin resistance helps explain a clinical pattern many clients recognise but struggle to articulate: eating to fullness but never feeling satisfied, combined with persistent appetite despite clearly adequate energy stores. This is not a psychological failure – it is the hypothalamus receiving a degraded signal from a system that has been progressively desensitised. Framing it this way in consultations consistently shifts the conversation from self-blame to problem-solving.

Leptin and Weight Loss: The Restriction Penalty

When caloric restriction produces weight loss, fat mass falls and circulating leptin falls with it – sometimes dramatically. A 10% reduction in body weight can produce a leptin decline of up to 50%, disproportionate to the fat mass lost, because adipose tissue also reduces its per-cell leptin secretion rate under energy deficit conditions. This leptin fall is perceived by the hypothalamus as a threat to energy stores, triggering compensatory responses: increased appetite, reduced energy expenditure, and heightened food-seeking behaviour. ^[4]

This is the leptin dimension of the weight regain problem – running in parallel to ghrelin rebound but through a distinct mechanism. Where ghrelin rebound represents an elevated hunger signal, leptin decline represents the removal of the satiety brake. Both operate simultaneously after weight loss, which is why the hunger experienced during and after caloric restriction is typically more intense than the hunger experienced before it: the system is being driven from two directions at once.

Critically, leptin sensitivity does not recover immediately when weight is regained. The hypothalamic inflammation and SOCS3-mediated desensitisation that developed during obesity can persist beyond the period of elevated leptin, meaning that the appetite regulation system may take considerably longer to recalibrate than the weight regain itself.

Leptin and the Skin: Wound Healing and Keratinocyte Function

Leptin receptor (Ob-R) expression in the skin is well-established, with receptors confirmed on epidermal keratinocytes, dermal fibroblasts, and endothelial cells. The functional significance of this expression is most clearly demonstrated in the ob/ob mouse model – leptin-deficient mice show significantly delayed wound healing, with impaired re-epithelialisation and reduced angiogenesis at wound sites. jci

In human keratinocyte research, leptin promotes proliferation, differentiation, and migration – all three processes required for normal wound re-epithelialisation. Topical leptin administration in wound models accelerated healing by increasing keratinocyte mitogenic activity and enhancing dermal angiogenesis around the wound margin. These findings establish leptin as a genuine growth factor signal in skin repair, not merely a peripheral association. journals.plos

The clinical implication for aesthetics practice is nuanced. At normal weight with functional leptin signalling, leptin contributes positively to the skin’s repair capacity – the same processes that support normal wound healing support recovery from aesthetic procedures. In states of significant caloric restriction, however, falling leptin removes one of the growth factor signals supporting keratinocyte proliferation and wound response, contributing to the slower recovery and reduced treatment responsiveness that chronically restricting clients sometimes present with. This is separate from – but additive to – the cortisol-mediated collagen suppression that accompanies the same restriction states.

At Creative Touch, the skin wound healing angle is practically relevant: clients in active caloric restriction may present with compromised procedure recovery that has a hormonal as well as a nutritional basis.